ArticleMedicine2020

Efficacy of ixazomib for the treatment of relapsed/refractory multiple myeloma: A protocol of systematic review and meta-analysis.

Zhi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.